Published in Pediatr Nephrol on April 27, 2005
Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension (2014) 1.55
Cardiac and vascular consequences of pre-hypertension in youth. J Clin Hypertens (Greenwich) (2011) 1.32
Assessment and management of hypertension in children and adolescents. Nat Rev Cardiol (2010) 1.20
The changing face of pediatric hypertension in the era of the childhood obesity epidemic. Pediatr Nephrol (2012) 1.07
Regression of target organ damage in children and adolescents with primary hypertension. Pediatr Nephrol (2010) 1.03
Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol (2006) 1.01
Intima-media thickness measurements in children with cardiovascular risk factors. Pediatr Nephrol (2008) 0.99
Childhood hypertension is not a silent disease. Pediatr Nephrol (2006) 0.98
Primary versus secondary hypertension in children followed up at an outpatient tertiary unit. Pediatr Nephrol (2010) 0.94
Inflammatory activation in children with primary hypertension. Pediatr Nephrol (2010) 0.90
Essential hypertension vs. secondary hypertension among children. Am J Hypertens (2014) 0.88
Development of hypertension in overweight adolescents: a review. Adolesc Health Med Ther (2015) 0.88
Blood pressure in children and target-organ damage later in life. Pediatr Nephrol (2009) 0.88
Use of antihypertensive medications and diagnostic tests among privately insured adolescents and young adults with primary versus secondary hypertension. J Adolesc Health (2014) 0.86
Focus on prevention, diagnosis and treatment of hypertension in children and adolescents. Ital J Pediatr (2013) 0.83
Blood pressure load, proteinuria and renal function in pre-hypertensive children. Pediatr Nephrol (2008) 0.82
Comparison of ambulatory blood pressure and Task Force criteria to identify pediatric hypertension. Pediatr Nephrol (2006) 0.82
Blood aldosterone-to-renin ratio, ambulatory blood pressure, and left ventricular mass in children. J Pediatr (2009) 0.82
Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension. Pediatr Nephrol (2011) 0.81
Effects of obesity and race on left ventricular geometry in hypertensive children. Pediatr Nephrol (2013) 0.81
Why should we screen for arterial hypertension in children and adolescents? Pediatr Nephrol (2017) 0.80
Primary hypertension and special aspects of hypertension in older children and adolescents. Adolesc Health Med Ther (2011) 0.80
Underlying Rationale and Approach to Treat Hypertension in Adolescents by Physicians of Different Specialty. Ann Pediatr Child Health (2015) 0.80
Different BMI cardiovascular risk thresholds as markers of organ damage and metabolic syndrome in primary hypertension. Pediatr Nephrol (2008) 0.79
Different pathomechanisms of essential and obesity-associated hypertension in adolescents. Pediatr Nephrol (2006) 0.79
Essential pediatric hypertension: defining the educational needs of primary care pediatricians. BMC Med Educ (2014) 0.78
Pediatric Hypertension Specialists' Perspectives About Adolescent Hypertension Management: Implications for Primary Care Providers. Clin Pediatr (Phila) (2014) 0.77
Primary hypertension in children and adolescents is an immuno-metabolic disease with hemodynamic consequences. Curr Hypertens Rep (2013) 0.77
Left Ventricular Hypertrophy Phenotype in Childhood-Onset Essential Hypertension. J Clin Hypertens (Greenwich) (2015) 0.76
Ambulatory Blood Pressure Monitoring in a Cohort of Children Referred with Suspected Hypertension: Characteristics of Children with and without Attention Deficit Hyperactivity Disorder. Int J Hypertens (2013) 0.76
Primary hypertension is a disease of premature vascular aging associated with neuro-immuno-metabolic abnormalities. Pediatr Nephrol (2015) 0.75
Casual blood pressure of adolescents attending public secondary schools in Maiduguri, Nigeria. Clin Hypertens (2015) 0.75
Remedial operations for failed endovascular therapy of 32 renal artery stenoses in 24 children. Pediatr Nephrol (2015) 0.75
CDC growth charts: United States. Adv Data (2000) 38.32
Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA (2002) 23.79
Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics (1987) 3.43
The kidney, hypertension, and obesity. Hypertension (2003) 2.79
Isolated systolic hypertension, obesity, and hyperkinetic hemodynamic states in children. J Pediatr (2002) 1.92
Secular trends of blood pressure and body size in a multi-ethnic adolescent population: 1986 to 1996. J Pediatr (1999) 1.88
Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension (2002) 1.87
A single pediatric center experience with 1025 children with hypertension. Acta Paediatr (1992) 1.15
Prevalence and consequence of systolic hypertension in children. Am J Hypertens (2002) 1.13
Etiology of sustained hypertension in children in the southwestern United States. Pediatr Nephrol (1994) 1.12
Persistent elevation of blood pressure among children with a family history of hypertension: the Minneapolis Children's Blood Pressure Study. J Hypertens (1988) 1.05
The adolescent with essential hypertension. Am J Kidney Dis (1985) 1.00
Obesity hypertension. Am J Hypertens (2002) 0.93
Childhood hypertension. An update on etiology, diagnosis, and treatment. Pediatr Clin North Am (1999) 0.92
Impact of ambulatory blood pressure monitoring on the management of hypertension in children. Blood Press Monit (2000) 0.92
Evaluation and management of hypertension in childhood. Prog Pediatr Cardiol (2001) 0.91
Differentiation between primary and secondary hypertension in children using ambulatory blood pressure monitoring. Pediatrics (2002) 0.89
Is there an epidemic of cardiovascular disease on the horizon? J Pediatr (1999) 0.85
Hypertension in children. Curr Probl Pediatr (1988) 0.83
Ambulatory blood pressure patterns in children and adolescents: influence of renin-sodium profiles. Pediatrics (1991) 0.81
Low-renin essential hypertension--another form of childhood hypertension. J Pediatr (1971) 0.77
Left ventricular hypertrophy in adolescents with elevated blood pressure: assessment by chest roentgenography, electrocardiography, and echocardiography. Pediatrics (1981) 0.76
Blood pressure and anthropometry in parents and children of a southern Italian village. J Hum Hypertens (1996) 0.75
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA (2003) 7.42
Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) (2002) 6.03
Sodium intake and mortality in the NHANES II follow-up study. Am J Med (2006) 3.24
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol (2007) 3.10
The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int (2004) 2.96
ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. Arch Intern Med (2009) 2.02
Sodium intake and mortality follow-up in the Third National Health and Nutrition Examination Survey (NHANES III). J Gen Intern Med (2008) 1.79
A call for higher standards of evidence for dietary guidelines. Am J Prev Med (2008) 1.69
Effect of physician volume on the relationship between hospital volume and mortality during primary angioplasty. J Am Coll Cardiol (2009) 1.67
Acute myocardial infarction hospitalization in the United States, 1979 to 2005. Am J Med (2010) 1.63
Renin-angiotensin system blockers may create more risk than reward for sodium-depleted cardiovascular patients with high plasma renin levels. Am J Hypertens (2013) 1.57
Hypertension control at physicians' offices in the United States. Am J Hypertens (2008) 1.56
Renal dysfunction and ischemic heart disease mortality in a hypertensive population. J Hypertens (2005) 1.55
Is high pulse pressure a marker of preclinical cardiovascular disease? Hypertension (2005) 1.53
Enduring direct association of baseline plasma renin activity with all-cause and cardiovascular mortality in hypertensive patients. Am J Hypertens (2011) 1.27
Blood-pressure-related disease is a global health priority. Lancet (2008) 1.22
The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. Vasc Med (2012) 1.13
Exercise, body mass index, caloric intake, and cardiovascular mortality. Am J Prev Med (2003) 1.10
Variations in hip fracture hospitalization rates among different race/ethnicity groups in New York City. Ethn Dis (2004) 1.08
Differential use of coronary revascularization and hospital mortality following acute myocardial infarction. Arch Intern Med (2003) 1.05
Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. J Clin Hypertens (Greenwich) (2011) 1.04
Impact of the increasing burden of diabetes on acute myocardial infarction in New York City: 1990-2000. Diabetes (2006) 1.02
Declining US stroke hospitalization since 1997: National Hospital Discharge Survey, 1988-2004. Neuroepidemiology (2008) 1.01
Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States. Am Heart J (2006) 1.00
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study. J Am Coll Cardiol (2004) 0.99
Clinical characteristics of stroke among Chinese in New York City. Ethn Dis (2004) 0.99
Dissociation of hospitalization and mortality trends for myocardial infarction in the United States from 1988 to 1997. Am J Med (2002) 0.98
Sodium and cardiovascular disease. N Engl J Med (2014) 0.95
Is geography destiny for patients in New York with myocardial infarction? Am J Med (2003) 0.95
Sodium, blood pressure, and cardiovascular disease. Curr Opin Cardiol (2007) 0.94
Vascular disease among hospitalized multiple sclerosis patients. Neuroepidemiology (2008) 0.93
Beyond hypertension toward guidelines for cardiovascular risk reduction. Am J Hypertens (2004) 0.92
The Cochrane review of sodium and health. Am J Hypertens (2011) 0.83
Gender differences of revascularization in patients with acute myocardial infarction. Am J Cardiol (2006) 0.82
Exercise and cardiovascular outcomes by hypertensive status: NHANES I epidemiological follow-up study, 1971-1992. Am J Hypertens (2005) 0.82
Quality of life in hypertensive patients: does it matter and should we measure it? J Hypertens (2005) 0.82
Stroke risk among Chinese immigrants in New York City. J Immigr Minor Health (2006) 0.81
Dietary Sodium and Cardiovascular Disease Risk. N Engl J Med (2016) 0.81
Access to revascularization among patients with acute myocardial infarction in New York City--impact of hospital resources. J Urban Health (2006) 0.80
Blood-pressure-related disease is a global health priority. Am J Hypertens (2008) 0.80
Blood-pressure-related disease is a global health priority. J Hypertens (2008) 0.79
Podagra, uric acid, and cardiovascular disease. Circulation (2007) 0.79
Resistant hypertension: a clinical syndrome in search of a definition. Am J Hypertens (2008) 0.78
Does blood pressure control require a Cuban-style revolution? J Hypertens (2006) 0.78
Hypertension control: improved, but not enough! Am J Hypertens (2007) 0.77
The return on INVEST. JAMA (2003) 0.76
More about plasma renin and cardiovascular mortality. Eur Heart J (2011) 0.75
Hypertension, silver bullets and faded dreams. J Hypertens (2004) 0.75
Blood pressure measures, relative and absolute risk, and international differences. J Hypertens (2002) 0.75
Hypertension in sub-Saharan Africa: what physicians can do! Am J Hypertens (2009) 0.75
Salt: data and speculation. Clin Auton Res (2002) 0.75
Estimation of death rates from pandemic influenza. Lancet (2007) 0.75
Does supplemental private insurance affect care of Medicare recipients hospitalized for myocardial infarction? Am J Public Health (2004) 0.75
Risk of hospitalized gastrointestinal bleeding in persons randomized to diuretic, ACE-inhibitor, or calcium-channel blocker in ALLHAT. J Clin Hypertens (Greenwich) (2013) 0.75
ALLHAT and beyond. Am J Hypertens (2003) 0.75
Dietary salt and cardiovascular disease. Lancet (2011) 0.75
Hypertension control and kidney disease: some questions answered, many remain. JAMA (2002) 0.75
AJH, globalization, and the Chinese Journal of Hypertension. Am J Hypertens (2009) 0.75
Revascularization among patients with acute myocardial infarction complicated by cardiogenic shock and impact of American College of Cardiology/American Heart Association guidelines. Am J Cardiol (2004) 0.75
Editor's Note. The Renin-Angiotensin System: Today and Tomorrow in Research and Clinical Practice. Am J Hypertens (2011) 0.75
Randomized clinical trials: prescriptions to be applied with caution! Am J Hypertens (2008) 0.75
The state of the journal: a report to AJH readers, reviewers, and authors. Am J Hypertens (2011) 0.75
AJH Peer Review 2014. Am J Hypertens (2015) 0.75
Glucose-cholesterol interaction magnifies coronary heart disease risk for hypertensive patients. Hypertension (2004) 0.75
AJH goes to China. Am J Hypertens (2008) 0.75
Clinical problems in the management of hypertension 1) Prehypertension: should we treat? 2)The very elderly: how should we treat. J Clin Hypertens (Greenwich) (2004) 0.75
How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure? Stat Med (2012) 0.75
Renal dysfunction predicts attenuation of ischemic heart disease mortality risk from elevated glucose among treated hypertensive patients. Am J Hypertens (2006) 0.75
Low sodium diet after DASH: has the situation changed? Dietary Approaches to Stop Hypertension. Curr Hypertens Rep (2002) 0.75